Home > Healthcare & Medical Devices > Clinical Trials Market > Table of Contents

Clinical Trials Market Size By Phases (Phase I, Phase II, Phase III, Phase IV), By Study Design (Interventional Study, Observational Study, Expanded Access Study), By Therapeutic Area (Autoimmune Disease, Oncology, Cardiology, Infectious Disease, Dermatology, Ophthalmology) Industry Analysis Report, Regional Outlook, Application Potential, Covid-19 Impact Analysis, Price Trends, Competitive Market Share & Forecast, 2022 – 2030

  • Report ID: GMI5029
  • Published Date: Jun 2022
  • Report Format: PDF

Report Content

Chapter 1   Methodology

1.1    Market definitions

1.2    Base estimates & working

1.2.1    North America

1.2.2    Europe

1.2.3    Asia Pacific

1.2.4    Latin America

1.2.5    Middle East & Africa

1.3    Forecast parameters

1.4    Data validation

1.5    Data Sources

1.5.1    Secondary

1.5.1.1   Paid sources

1.5.1.2   Unpaid sources

1.5.2    Primary

Chapter 2   Executive Summary

2.1    Clinical trials industry 360° synopsis, 2017-2030

2.1.1    Business trends

2.1.2    Phase trends

2.1.3    Study design trends

2.1.4    Therapeutic area trends

2.1.5    Regional trends

Chapter 3   Clinical trials Industry Insights

3.1    Industry segmentation

3.2    Industry landscape, 2017-2030 (USD Million)

3.3    Industry impact forces

3.3.1    Growth drivers

3.3.1.1   Increasing prevalence of chronic diseases across the globe

3.3.1.2   Growing demand for outsourcing clinical trials to CROs

3.3.1.3   Rise in government and non-government funding for clinical trials

3.3.1.4   Growing opportunities for conducting clinical trials in countries of Asia Pacific

3.3.2    Industry pitfalls & challenges

3.3.2.1   Lack of skilled workforce in clinical research

3.3.2.2   Infrastructural barriers in developing countries

3.3.2.3   Challenges faced in North America & Europe for conducting clinical trials

3.4    Growth potential analysis

3.4.1    By phase

3.4.2    By study design

3.4.3    By therapeutic areas

3.5    COVID-19 impact analysis

3.6    Clinical trial volume analysis

3.6.1    Clinical trial volume analysis, by region, 2017-2020

3.6.2    Clinical trial volume analysis, by indication, 2017-2020

3.6.3    Clinical trial volume analysis, by phase of development, 2017-2020

3.7    Regulatory landscape

3.7.1    U.S.

3.7.2    Europe

3.7.3    Asia Pacific

3.7.3.1   Singapore

3.7.3.2   Malaysia

3.7.3.3   Indonesia

3.7.3.4   Thailand

3.7.3.5   South Korea

3.7.3.6   Philippines

3.8    Clinical trials- Asia Pacific advantage

3.9    Competitive landscape, 2021

3.9.1    Company matrix analysis

3.10    Porter's analysis

3.11    PESTEL analysis

Chapter 4   Clinical Trials Market, By Phase

4.1    Key segment trends

4.2    Phase I

4.2.1    Market size, by region, 2017-2030 (USD Million)

4.3    Phase II

4.3.1    Market size, by region, 2017-2030 (USD Million)

4.4    Phase III

4.4.1    Market size, by region, 2017-2030 (USD Million)

4.5    Phase IV

4.5.1    Market size, by region, 2017-2030 (USD Million)

Chapter 5   Clinical Trials Market, By Study Design

5.1    Key segment trend

5.2    Interventional study

5.2.1    Market size, by region, 2017-2030 (USD Million)

5.3    Observational study

5.3.1    Market size, by region, 2017-2030 (USD Million)

5.4    Expanded access study

5.4.1    Market size, by region, 2017-2030 (USD Million)

Chapter 6   Clinical Trials Market, By Therapeutic Area

6.1    Key segment trend

6.2    Autoimmune disease

6.2.1    Market size, by region, 2017-2030 (USD Million)

6.3    Oncology

6.3.1    Market size, by region, 2017-2030 (USD Million)

6.4    Cardiology

6.4.1    Market size, by region, 2017-2030 (USD Million)

6.5    Infectious disease

6.5.1    Market size, by region, 2017-2030 (USD Million)

6.6    Dermatology

6.6.1    Market size, by region, 2017-2030 (USD Million)

6.7    Ophthalmology

6.7.1    Market size, by region, 2017-2030 (USD Million)

6.8    Others

6.8.1    Market size, by region, 2017-2030 (USD Million)

Chapter 7   Clinical Trials Market, By Region

7.1    Key regional trends

7.2    North America

7.2.1    Market size, by country, 2017-2030 (USD Million)

7.2.2    Market size, by phase, 2017-2030 (USD Million)

7.2.3    Market size, by study design, 2017-2030 (USD Million)

7.2.4    Market size, by therapeutic area, 2017-2030 (USD Million)

7.2.5    U.S.

7.2.5.1   Market size, by phase, 2017-2030 (USD Million)

7.2.5.2   Market size, by study design, 2017-2030 (USD Million)

7.2.5.3   Market size, by therapeutic area, 2017-2030 (USD Million)

7.2.6    Canada

7.2.6.1   Market size, by phase, 2017-2030 (USD Million)

7.2.6.2   Market size, by study design, 2017-2030 (USD Million)

7.2.6.3   Market size, by therapeutic area, 2017-2030 (USD Million)

7.3    Europe

7.3.1    Market size, by country, 2017-2030 (USD Million)

7.3.2    Market size, by phase, 2017-2030 (USD Million)

7.3.3    Market size, by study design, 2017-2030 (USD Million)

7.3.4    Market size, by therapeutic area, 2017-2030 (USD Million)

7.3.5    Germany

7.3.5.1   Market size, by phase, 2017-2030 (USD Million)

7.3.5.2   Market size, by study design, 2017-2030 (USD Million)

7.3.5.3   Market size, by therapeutic area, 2017-2030 (USD Million)

7.3.6    UK

7.3.6.1   Market size, by phase, 2017-2030 (USD Million)

7.3.6.2   Market size, by study design, 2017-2030 (USD Million)

7.3.6.3   Market size, by therapeutic area, 2017-2030 (USD Million)

7.3.7    France

7.3.7.1   Market size, by phase, 2017-2030 (USD Million)

7.3.7.2   Market size, by study design, 2017-2030 (USD Million)

7.3.7.3   Market size, by therapeutic area, 2017-2030 (USD Million)

7.3.8    Spain

7.3.8.1   Market size, by phase, 2017-2030 (USD Million)

7.3.8.2   Market size, by study design, 2017-2030 (USD Million)

7.3.8.3   Market size, by therapeutic area, 2017-2030 (USD Million)

7.3.9    Italy

7.3.9.1   Market size, by phase, 2017-2030 (USD Million)

7.3.9.2   Market size, by study design, 2017-2030 (USD Million)

7.3.9.3   Market size, by therapeutic area, 2017-2030 (USD Million)

7.4    Asia Pacific

7.4.1    Market size, by country, 2017-2030 (USD Million)

7.4.2    Market size, by phase, 2017-2030 (USD Million)

7.4.3    Market size, by study design, 2017-2030 (USD Million)

7.4.4    Market size, by therapeutic area, 2017-2030 (USD Million)

7.4.5    China

7.4.5.1   Market size, by phase, 2017-2030 (USD Million)

7.4.5.2   Market size, by study design, 2017-2030 (USD Million)

7.4.5.3   Market size, by therapeutic area, 2017-2030 (USD Million)

7.4.6    Japan

7.4.6.1   Market size, by phase, 2017-2030 (USD Million)

7.4.6.2   Market size, by study design, 2017-2030 (USD Million)

7.4.6.3   Market size, by therapeutic area, 2017-2030 (USD Million)

7.4.7    India

7.4.7.1   Market size, by phase, 2017-2030 (USD Million)

7.4.7.2   Market size, by study design, 2017-2030 (USD Million)

7.4.7.3   Market size, by therapeutic area, 2017-2030 (USD Million)

7.4.8    Australia

7.4.8.1   Market size, by phase, 2017-2030 (USD Million)

7.4.8.2   Market size, by study design, 2017-2030 (USD Million)

7.4.8.3   Market size, by therapeutic area, 2017-2030 (USD Million)

7.4.9    South Korea

7.4.9.1   Market size, by phase, 2017-2030 (USD Million)

7.4.9.2   Market size, by study design, 2017-2030 (USD Million)

7.4.9.3   Market size, by therapeutic area, 2017-2030 (USD Million)

7.4.10    Singapore

7.4.10.1    Market size, by phase, 2017-2030 (USD Million)

7.4.10.2    Market size, by study design, 2017-2030 (USD Million)

7.4.10.3    Market size, by therapeutic area, 2017-2030 (USD Million)

7.4.11    Malaysia

7.4.11.1    Market size, by phase, 2017-2030 (USD Million)

7.4.11.2    Market size, by study design, 2017-2030 (USD Million)

7.4.11.3    Market size, by therapeutic area, 2017-2030 (USD Million)

7.4.12    Indonesia

7.4.12.1    Market size, by phase, 2017-2030 (USD Million)

7.4.12.2    Market size, by study design, 2017-2030 (USD Million)

7.4.12.3    Market size, by therapeutic area, 2017-2030 (USD Million)

7.4.13    Thailand

7.4.13.1    Market size, by phase, 2017-2030 (USD Million)

7.4.13.2    Market size, by study design, 2017-2030 (USD Million)

7.4.13.3    Market size, by therapeutic area, 2017-2030 (USD Million)

7.4.14    Philippines

7.4.14.1    Market size, by phase, 2017-2030 (USD Million)

7.4.14.2    Market size, by study design, 2017-2030 (USD Million)

7.4.14.3    Market size, by therapeutic area, 2017-2030 (USD Million)

7.5    Latin America

7.5.1    Market size, by country, 2017-2030 (USD Million)

7.5.2    Market size, by phase, 2017-2030 (USD Million)

7.5.3    Market size, by study design, 2017-2030 (USD Million)

7.5.4    Market size, by therapeutic area, 2017-2030 (USD Million)

7.5.5    Brazil

7.5.5.1   Market size, by phase, 2017-2030 (USD Million)

7.5.5.2   Market size, by study design, 2017-2030 (USD Million)

7.5.5.3   Market size, by therapeutic area, 2017-2030 (USD Million)

7.5.6    Mexico

7.5.6.1   Market size, by phase, 2017-2030 (USD Million)

7.5.6.2   Market size, by study design, 2017-2030 (USD Million)

7.5.6.3   Market size, by therapeutic area, 2017-2030 (USD Million)

7.6    Middle East and Africa

7.6.1    Market size, by country, 2017-2030 (USD Million)

7.6.2    Market size, by phase, 2017-2030 (USD Million)

7.6.3    Market size, by study design, 2017-2030 (USD Million)

7.6.4    Market size, by therapeutic area, 2017-2030 (USD Million)

7.6.5    South Africa

7.6.5.1   Market size, by phase, 2017-2030 (USD Million)

7.6.5.2   Market size, by study design, 2017-2030 (USD Million)

7.6.5.3   Market size, by therapeutic area, 2017-2030 (USD Million)

7.6.6    Saudi Arabia

7.6.6.1   Market size, by phase, 2017-2030 (USD Million)

7.6.6.2   Market size, by study design, 2017-2030 (USD Million)

7.6.6.3   Market size, by therapeutic area, 2017-2030 (USD Million)

Chapter 8   Company Profiles

8.1    Competitive dashboard, 2021

8.2    Clario

8.2.1    Business overview

8.2.2    Financial data

8.2.3    Product landscape

8.2.4    Strategic outlook

8.2.5    SWOT analysis

8.3    Charles River Laboratories (MPI Research)

8.3.1    Business overview

8.3.2    Financial data

8.3.3    Product landscape

8.3.4    Strategic outlook

8.3.5    SWOT analysis

8.4    Clinipace Inc

8.4.1    Business overview

8.4.2    Financial data

8.4.3    Product landscape

8.4.4    Strategic outlook

8.4.5    SWOT analysis

8.5    ICON plc

8.5.1    Business overview

8.5.2    Financial data

8.5.3    Product landscape

8.5.4    Strategic outlook

8.5.5    SWOT analysis

8.6    IQVIA

8.6.1    Business overview

8.6.2    Financial data

8.6.3    Product landscape

8.6.4    Strategic outlook

8.6.5    SWOT analysis

8.7    Laboratory Corporation of America Holding (Covance Inc)

8.7.1    Business overview

8.7.2    Financial data

8.7.3    Product landscape

8.7.4    Strategic outlook

8.7.5    SWOT analysis

8.8    Medpace

8.8.1    Business overview

8.8.2    Financial data

8.8.3    Product landscape

8.8.4    Strategic outlook

8.8.5    SWOT analysis

8.9    Parexel International Corporation

8.9.1    Business overview

8.9.2    Financial data

8.9.3    Product landscape

8.9.4    Strategic outlook

8.9.5    SWOT analysis

8.10    Pharmaceutical Product Development, LLC (PPD)

8.10.1    Business overview

8.10.2    Financial data

8.10.3    Product landscape

8.10.4    Strategic outlook

8.10.5    SWOT analysis

8.11    Syneos health

8.11.1    Business overview

8.11.2    Financial data

8.11.3    Product landscape

8.11.4    Strategic outlook

8.11.5    SWOT analysis

8.12    The Emmes Company, LLC

8.12.1    Business overview

8.12.2    Financial data

8.12.3    Product landscape

8.12.4    Strategic outlook

8.12.5    SWOT analysis

8.13    WuXi AppTec

8.13.1    Business overview

8.13.2    Financial data

8.13.3    Product landscape

8.13.4    Strategic outlook

8.13.5    SWOT analysis
 

Data Tables

TABLE 1    Global clinical trials market, 2017-2021 (USD Million)

TABLE 2    Global clinical trials market, 2022-2030 (USD Million)

TABLE 3    Global clinical trials market, by phase, 2017-2021 (USD Million)

TABLE 4    Global clinical trials market, by phase, 2022-2030 (USD Million)

TABLE 5    Global clinical trials market, by study design, 2017-2021 (USD Million)

TABLE 6    Global clinical trials market, by study design, 2022-2030 (USD Million)

TABLE 7    Global clinical trials market, by therapeutic area, 2017-2021 (USD Million)

TABLE 8    Global clinical trials market, by therapeutic area, 2022-2030 (USD Million)

TABLE 9    Global clinical trials market, by region, 2017-2021 (USD Million)

TABLE 10    Global clinical trials market, by region, 2022-2030 (USD Million)

TABLE 11    Industry impact forces

TABLE 12    Clinical trial volume analysis, by region, 2017-2020

TABLE 13    Clinical trial volume analysis, by indication, 2017-2020

TABLE 14    Clinical trial volume analysis, by phase of development, 2017-2020

TABLE 15    Phase I market size, by region, 2017-2021(USD Million)

TABLE 16    Phase I market size, by region, 2022-2030 (USD Million)

TABLE 17    Phase II market size, by region, 2017-2021 (USD Million)

TABLE 18    Phase II market size, by region, 2022-2030 (USD Million)

TABLE 19    Phase III market size, by region, 2017-2021 (USD Million)

TABLE 20    Phase III market size, by region, 2022-2030 (USD Million)

TABLE 21    Phase IV market size, by region, 2017-2021 (USD Million)

TABLE 22    Phase IV market size, by region, 2022-2030 (USD Million)

TABLE 23    Interventional study market size, by region, 2017-2021 (USD Million)

TABLE 24    Interventional study market size, by region, 2022-2030 (USD Million)

TABLE 25    Observational study market size, by region, 2017-2021 (USD Million)

TABLE 26    Observational study market size, by region, 2022-2030 (USD Million)

TABLE 27    Expanded access study market size, by region, 2017-2021 (USD Million)

TABLE 28    Expanded access study market size, by region, 2022-2030 (USD Million)

TABLE 29    Autoimmune disease market size, by region, 2017-2021 (USD Million)

TABLE 30    Autoimmune disease market size, by region, 2022-2030 (USD Million)

TABLE 31    Oncology market size, by region, 2017-2021 (USD Million)

TABLE 32    Oncology market size, by region, 2022-2030 (USD Million)

TABLE 33    Cardiology market size, by region, 2017-2021 (USD Million)

TABLE 34    Cardiology market size, by region, 2022-2030 (USD Million)

TABLE 35    Infectious disease market size, by region, 2017-2021 (USD Million)

TABLE 36    Infectious disease market size, by region, 2022-2030 (USD Million)

TABLE 37    Dermatology market size, by region, 2017-2021 (USD Million)

TABLE 38    Dermatology market size, by region, 2021 – 20207 (USD Million)

TABLE 39    Ophthalmology market size, by region, 2017-2021 (USD Million)

TABLE 40    Ophthalmology market size, by region, 2022-2030 (USD Million)

TABLE 41    Others market size, by region, 2017-2021 (USD Million)

TABLE 42    Others market size, by region, 2022-2030 (USD Million)

TABLE 43    North America clinical trials market size, by country, 2017-2021 (USD Million)

TABLE 44    North America clinical trials market size, by country, 2022-2030 (USD Million)

TABLE 45    North America clinical trials market size, by phase, 2017-2021 (USD Mn)

TABLE 46    North America clinical trials market size, by phase, 2022-2030 (USD Mn)

TABLE 47    North America clinical trials market size, by study design, 2017-2021 (USD Million)

TABLE 48    North America clinical trials market size, by study design, 2022-2030 (USD Million)

TABLE 49    North America clinical trials market size, by therapeutic area, 2017-2021 (USD Million)

TABLE 50    North America clinical trials market size, by therapeutic area, 2022-2030 (USD Million)

TABLE 51    U.S. clinical trials market size, by phase, 2017-2021 (USD Million)

TABLE 52    U.S. clinical trials market size, by phase, 2022-2030 (USD Million)

TABLE 53    U.S.    clinical trials market size, by study design, 2017-2021 (USD Million)

TABLE 54    U.S. clinical trials market size, by study design, 2022-2030 (USD Million)

TABLE 55    U.S. clinical trials market size, by therapeutic area, 2017-2021 (USD Million)

TABLE 56    U.S. clinical trials market size, by therapeutic area, 2022-2030 (USD Million)

TABLE 57    Canada clinical trials market size, by phase, 2017-2021 (USD Million)

TABLE 58    Canada clinical trials market size, by phase, 2022-2030 (USD Million)

TABLE 59    Canada clinical trials market size, by study design, 2017-2021 (USD Million)

TABLE 60    Canada clinical trials market size, by study design, 2022-2030 (USD Million)

TABLE 61    Canada clinical trials market size, by therapeutic area, 2017-2021 (USD Million)

TABLE 62    Canada clinical trials market size, by therapeutic area, 2022-2030 (USD Million)

TABLE 63    Europe clinical trials market size, by country, 2017-2021 (USD Million)

TABLE 64    Europe clinical trials market size, by country, 2022-2030 (USD Million)

TABLE 65    Europe clinical trials market size, by phase, 2017-2021 (USD Million)

TABLE 66    Europe clinical trials market size, by phase, 2022-2030 (USD Million)

TABLE 67    Europe clinical trials market size, by study design, 2017-2021 (USD Million)

TABLE 68    Europe clinical trials market size, by study design, 2022-2030 (USD Million)

TABLE 69    Europe clinical trials market size, by therapeutic area, 2017-2021 (USD Million)

TABLE 70    Europe clinical trials market size, by therapeutic area, 2022-2030 (USD Million)

TABLE 71    Germany clinical trials market size, by phase, 2017-2021 (USD Million)

TABLE 72    Germany clinical trials market size, by phase, 2022-2030 (USD Million)

TABLE 73    Germany clinical trials market size, by study design, 2017-2021 (USD Million)

TABLE 74    Germany clinical trials market size, by study design, 2022-2030 (USD Million)

TABLE 75    Germany clinical trials market size, by therapeutic area, 2017-2021 (USD Million)

TABLE 76    Germany clinical trials market size, by therapeutic area, 2022-2030 (USD Million)

TABLE 77    UK clinical trials market size, by phase, 2017-2021 (USD Million)

TABLE 78    UK clinical trials market size, by phase, 2022-2030 (USD Million)

TABLE 79    UK clinical trials market size, by study design, 2017-2021 (USD Million)

TABLE 80    UK clinical trials market size, by study design, 2022-2030 (USD Million)

TABLE 81    UK clinical trials market size, by therapeutic area, 2017-2021 (USD Million)

TABLE 82    UK clinical trials market size, by therapeutic area, 2022-2030 (USD Million)

TABLE 83    France clinical trials market size, by phase, 2017-2021 (USD Million)

TABLE 84    France clinical trials market size, by phase, 2022-2030 (USD Million)

TABLE 85    France clinical trials market size, by study design, 2017-2021 (USD Million)

TABLE 86    France clinical trials market size, by study design, 2022-2030 (USD Million)

TABLE 87    France clinical trials market size, by therapeutic area, 2017-2021 (USD Million)

TABLE 88    France clinical trials market size, by therapeutic area, 2022-2030 (USD Million)

TABLE 89    Spain clinical trials market size, by phase, 2017-2021 (USD Million)

TABLE 90    Spain clinical trials market size, by phase, 2022-2030 (USD Million)

TABLE 91    Spain clinical trials market size, by study design, 2017-2021 (USD Million)

TABLE 92    Spain clinical trials market size, by study design, 2022-2030 (USD Million)

TABLE 93    Spain clinical trials market size, by therapeutic area, 2017-2021 (USD Million)

TABLE 94    Spain clinical trials market size, by therapeutic area, 2022-2030 (USD Million)

TABLE 95    Italy clinical trials market size, by phase, 2017-2021 (USD Million)

TABLE 96    Italy clinical trials market size, by phase, 2022-2030 (USD Million)

TABLE 97    Italy clinical trials market size, by study design, 2017-2021 (USD Million)

TABLE 98    Italy clinical trials market size, by study design, 2022-2030 (USD Million)

TABLE 99    Italy clinical trials market size, by therapeutic area, 2017-2021 (USD Million)

TABLE 100    Italy clinical trials market size, by therapeutic area, 2022-2030 (USD Million)

TABLE 101    Asia Pacific clinical trials market size, by country, 2017-2021 (USD Million)

TABLE 102    Asia Pacific clinical trials market size, by country, 2022-2030 (USD Million)

TABLE 103    Asia Pacific clinical trials market size, by phase, 2017-2021 (USD Million)

TABLE 104    Asia Pacific clinical trials market size, by phase, 2022-2030 (USD Million)

TABLE 105    Asia Pacific clinical trials market size, by study design, 2017-2021 (USD Million)

TABLE 106    Asia Pacific clinical trials market size, by study design, 2022-2030 (USD Million)

TABLE 107    Asia Pacific clinical trials market size, by therapeutic area, 2017-2021 (USD Million)

TABLE 108    Asia Pacific clinical trials market size, by therapeutic area, 2022-2030 (USD Million)

TABLE 109    China clinical trials market size, by phase, 2017-2021 (USD Million)

TABLE 110    China clinical trials market size, by phase, 2022-2030 (USD Million)

TABLE 111    China clinical trials market size, by study design, 2017-2021 (USD Million)

TABLE 112    China clinical trials market size, by study design, 2022-2030 (USD Million)

TABLE 113    China clinical trials market size, by therapeutic area, 2017-2021 (USD Million)

TABLE 114    China clinical trials market size, by therapeutic area, 2022-2030 (USD Million)

TABLE 115    Japan clinical trials market size, by phase, 2017-2021 (USD Million)

TABLE 116    Japan clinical trials market size, by phase, 2022-2030 (USD Million)

TABLE 117    Japan clinical trials market size, by study design, 2017-2021 (USD Million)

TABLE 118    Japan clinical trials market size, by study design, 2022-2030 (USD Million)

TABLE 119    Japan clinical trials market size, by therapeutic area, 2017-2021 (USD Million)

TABLE 120    Japan clinical trials market size, by therapeutic area, 2022-2030 (USD Million)

TABLE 121    India clinical trials market size, by phase, 2017-2021 (USD Million)

TABLE 122    India clinical trials market size, by phase, 2022-2030 (USD Million)

TABLE 123    India clinical trials market size, by study design, 2017-2021 (USD Million)

TABLE 124    India clinical trials market size, by study design, 2022-2030 (USD Million)

TABLE 125    India clinical trials market size, by therapeutic area, 2017-2021 (USD Million)

TABLE 126    India clinical trials market size, by therapeutic area, 2022-2030 (USD Million)

TABLE 127    Australia clinical trials market size, by phase, 2017-2021 (USD Million)

TABLE 128    Australia clinical trials market size, by phase, 2022-2030 (USD Million)

TABLE 129    Australia clinical trials market size, by study design, 2017-2021 (USD Million)

TABLE 130    Australia clinical trials market size, by study design, 2022-2030 (USD Million)

TABLE 131    Australia clinical trials market size, by therapeutic area, 2017-2021 (USD Million)

TABLE 132    Australia clinical trials market size, by therapeutic area, 2022-2030 (USD Million)

TABLE 133    South Korea clinical trials market size, by phase, 2017-2021 (USD Million)

TABLE 134    South Korea clinical trials market size, by phase, 2022-2030 (USD Million)

TABLE 135    South Korea clinical trials market size, by study design, 2017-2021 (USD Million)

TABLE 136    South Korea clinical trials market size, by study design, 2022-2030 (USD Million)

TABLE 137    South Korea clinical trials market size, by therapeutic area, 2017-2021 (USD Million)

TABLE 138    South Korea clinical trials market size, by therapeutic area, 2022-2030 (USD Million)

TABLE 139    Singapore clinical trials market size, by phase, 2017-2021 (USD Million)

TABLE 140    Singapore clinical trials market size, by phase, 2022-2030 (USD Million)

TABLE 141    Singapore clinical trials market size, by study design, 2017-2021 (USD Million)

TABLE 142    Singapore clinical trials market size, by study design, 2022-2030 (USD Million)

TABLE 143    Singapore clinical trials market size, by therapeutic area, 2017-2021 (USD Million)

TABLE 144    Singapore clinical trials market size, by therapeutic area, 2022-2030 (USD Million)

TABLE 145    Malaysia clinical trials market size, by phase, 2017-2021 (USD Million)

TABLE 146    Malaysia clinical trials market size, by phase, 2022-2030 (USD Million)

TABLE 147    Malaysia clinical trials market size, by study design, 2017-2021 (USD Million)

TABLE 148    Malaysia clinical trials market size, by study design, 2022-2030 (USD Million)

TABLE 149    Malaysia clinical trials market size, by therapeutic area, 2017-2021 (USD Million)

TABLE 150    Malaysia clinical trials market size, by therapeutic area, 2022-2030 (USD Million)

TABLE 151    Indonesia clinical trials market size, by phase, 2017-2021 (USD Million)

TABLE 152    Indonesia clinical trials market size, by phase, 2022-2030 (USD Million)

TABLE 153    Indonesia clinical trials market size, by study design, 2017-2021 (USD Million)

TABLE 154    Indonesia clinical trials market size, by study design, 2022-2030 (USD Million)

TABLE 155    Indonesia clinical trials market size, by therapeutic area, 2017-2021 (USD Million)

TABLE 156    Indonesia clinical trials market size, by therapeutic area, 2022-2030 (USD Million)

TABLE 157    Thailand clinical trials market size, by phase, 2017-2021 (USD Million)

TABLE 158    Thailand clinical trials market size, by phase, 2022-2030 (USD Million)

TABLE 159    Thailand clinical trials market size, by study design, 2017-2021 (USD Million)

TABLE 160    Thailand clinical trials market size, by study design, 2022-2030 (USD Million)

TABLE 161    Thailand clinical trials market size, by therapeutic area, 2017-2021 (USD Million)

TABLE 162    Thailand clinical trials market size, by therapeutic area, 2022-2030 (USD Million)

TABLE 163    Philippines clinical trials market size, by phase, 2017-2021 (USD Million)

TABLE 164    Philippines clinical trials market size, by phase, 2022-2030 (USD Million)

TABLE 165    Philippines clinical trials market size, by study design, 2017-2021 (USD Million)

TABLE 166    Philippines clinical trials market size, by study design, 2022-2030 (USD Million)

TABLE 167    Philippines clinical trials market size, by therapeutic area, 2017-2021 (USD Million)

TABLE 168    Philippines clinical trials market size, by therapeutic area, 2022-2030 (USD Million)

TABLE 169    Latin America clinical trials market size, by country, 2017-2021 (USD Million)

TABLE 170    Latin America clinical trials market size, by country, 2022-2030 (USD Million)

TABLE 171    Latin America clinical trials market size, by phase, 2017-2021 (USD Million)

TABLE 172    Latin America clinical trials market size, by phase, 2022-2030 (USD Million)

TABLE 173    Latin America clinical trials market size, by study design, 2017-2021 (USD Million)

TABLE 174    Latin America clinical trials market size, by study design, 2022-2030 (USD Million)

TABLE 175    Latin America clinical trials market size, by therapeutic area, 2017-2021 (USD Million)

TABLE 176    Latin America clinical trials market size, by therapeutic area, 2022-2030 (USD Million)

TABLE 177    Brazil clinical trials market size, by phase, 2017-2021 (USD Million)

TABLE 178    Brazil clinical trials market size, by phase, 2022-2030 (USD Million)

TABLE 179    Brazil clinical trials market size, by study design, 2017-2021 (USD Million)

TABLE 180    Brazil clinical trials market size, by study design, 2022-2030 (USD Million)

TABLE 181    Brazil clinical trials market size, by therapeutic area, 2017-2021 (USD Million)

TABLE 182    Brazil clinical trials market size, by therapeutic area, 2022-2030 (USD Million)

TABLE 183    Mexico clinical trials market size, by phase, 2017-2021 (USD Million)

TABLE 184    Mexico clinical trials market size, by phase, 2022-2030 (USD Million)

TABLE 185    Mexico clinical trials market size, by study design, 2017-2021 (USD Million)

TABLE 186    Mexico clinical trials market size, by study design, 2022-2030 (USD Million)

TABLE 187    Mexico clinical trials market size, by therapeutic area, 2017-2021 (USD Million)

TABLE 188    Mexico clinical trials market size, by therapeutic area, 2022-2030 (USD Million)

TABLE 189    Middle East & Africa clinical trials market size, by country, 2017-2021 (USD Million)

TABLE 190    Middle East & Africa clinical trials market size, by country, 2022-2030 (USD Million)

TABLE 191    Middle East & Africa clinical trials market size, by phase, 2017-2021 (USD Million)

TABLE 192    Middle East & Africa clinical trials market size, by phase, 2022-2030 (USD Million)

TABLE 193    Middle East & Africa clinical trials market size, by study design, 2017-2021 (USD Million)

TABLE 194    Middle East & Africa clinical trials market size, by study design, 2022-2030 (USD Million)

TABLE 195    Middle East & Africa clinical trials market size, by therapeutic area, 2017-2021 (USD Million)

TABLE 196    Middle East & Africa clinical trials market size, by therapeutic area, 2022-2030 (USD Million)

TABLE 197    South Africa clinical trials market size, by phase, 2017-2021 (USD Million)

TABLE 198    South Africa clinical trials market size, by phase, 2022-2030 (USD Million)

TABLE 199    South Africa clinical trials market size, by study design, 2017-2021 (USD Million)

TABLE 200    South Africa clinical trials market size, by study design, 2022-2030 (USD Million)

TABLE 201    South Africa clinical trials market size, by therapeutic area, 2017-2021 (USD Million)

TABLE 202    South Africa clinical trials market size, by therapeutic area, 2022-2030 (USD Million)

TABLE 203    Saudi Arabia clinical trials market size, by phase, 2017-2021 (USD Million)

TABLE 204    Saudi Arabia clinical trials market size, by phase, 2022-2030 (USD Million)

TABLE 205    Saudi Arabia clinical trials market size, by study design, 2017-2021 (USD Million)

TABLE 206    Saudi Arabia clinical trials market size, by study design, 2022-2030 (USD Million)

TABLE 207    Saudi Arabia clinical trials market size, by therapeutic area, 2017-2021 (USD Million)

TABLE 208    Saudi Arabia clinical trials market size, by therapeutic area, 2022-2030 (USD Million)


Charts & Figures

FIG. 1    Top-down approach

FIG. 2    Breakdown of primary participants

FIG. 3    Clinical trials industry 3600 synopsis, 2017-2030

FIG. 4    Industry segmentation

FIG. 5    Industry landscape, 2017-2030 (USD Million)

FIG. 6    Growth potential analysis, by phase

FIG. 7    Growth potential analysis, by study design

FIG. 8    Growth potential analysis, by therapeutic area

FIG. 9    Company matrix analysis, 2021

FIG. 10    Porter’s analysis

FIG. 11    PESTEL analysis

FIG. 12    Key segment trends, by phase

FIG. 13    Key segment trends, by study design

FIG. 14    Key segment trends, by therapeutic area

FIG. 15    Key regional trends

FIG. 16    Competitive dashboard, 2021
 

Authors: Rupali Swain, Subodh Kharad

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies
Immediate Delivery Available

Premium Report Details

  • Base Year: 2021
  • Companies covered: 12
  • Tables & Figures: 224
  • Countries covered: 21
  • Pages: 150

Get a report that explains COVID-19 impact on this market

 Request Free Sample

Budget constraints? Get in touch with us for special pricing

Request Discount